UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in SRRK — Scholar Rock Holding Corp
CIK 861177
NEW YORK, NY
Position in SRRK
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,059,150
+$337,743 QoQ
Shares Held
102,912
-4.0% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 36.90143034825871.ToString("F0")%
Shared 0.ToString("F0")%
None 63.0985696517413.ToString("F0")%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. SRRK ranks #64 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in SRRK
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,059,150 | 102,912 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $4,721,407 | 107,183 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,092,822 | 109,904 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,264,107 | 205,085 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,459,871 | 169,825 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $5,844,680 | 135,231 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $759,305 | 94,795 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $737,419 | 88,526 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,076,590 | 60,619 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,067,424 | 56,778 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $364,952 | 51,402 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $311,302 | 41,287 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $330,296 | 41,287 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $323,797 | 35,779 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $108,343 | 15,634 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $85,830 | 15,634 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $201,522 | 15,634 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $617,844 | 24,873 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $552,720 | 16,739 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $483,756 | 16,739 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $771,702 | 15,233 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $802,200 | 16,530 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $219,886 | 12,430 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||